Merck Animal Health, a division of Merck & Co. Inc., announced Feb. 13 increased investment and expansion opportunities in its U.S. manufacturing and ...

My Deep Value Dividend Growth Portfolio is always looking for the best low-risk dividend growth ideas, including those in recession-proof industries.

Merck & Co/MSD has pressed the accelerator on plans to set up Keytruda as the go-to cancer immunotherapy for prostate cancer, building on its already ...

Application Based on Overall Survival and Progression-Free Survival Data from Phase 3 KEYNOTE-426 Trial. February 15, 2019 06:45 AM Eastern Standard ...

Merck & Co., Inc. (NYSE:MRK) Director Wendell P. Weeks sold 5000 shares of the company's stock in a transaction that occurred on Wednesday, February 13th.

Merck is set to acquire the Antelliq Group for $2.37 billion, Drovers Daily reports. Merck will also assume the company's remaining debt. Antelliq will.

Merck Animal Health, a division of Merck & Co. Inc., announced Feb. 12 a collaboration agreement with Rapid Genomics that grants Merck Animal Health ...

Merck & Co. MRK, +0.64% said Friday it had net income of $1.827 billion, or 69 cents a share, in the fourth quarter, after a loss of $1.046 billion, or 39 cents a ...

GlaxoSmithKline Plc will pay Germany's Merck KGaA as much as 3.7 billion euros ($4.2 billion) to get access to a promising immune-oncology treatment that the ...

Bank of America Merrill Lynch on Tuesday named Merck its top pick among the many U.S. pharmaceutical stocks thanks to the growing success of its key cancer ...

Merck earnings and sales topped forecasts Friday, prompting Merck stock to rise. Keytruda sales lagged in the U.S., but beat internationally.

GSK collaborates with Merck KGaA on M7824, a TGF-beta. M7824 represents a class of agents considered to be the future of Immuno-Oncology. Late stage ...

'Halftime Report' traders Jon and Pete Najarian spot unusual options activity in shares of Applied Materials, Encana, eBay, and Merck.

Hemispherx Biopharma (NYSE:HEB) - Last month, tests started for combination therapy targeting metastatic, triple-negative breast cancer.

These are the stocks posting the largest moves midday Friday.

FDA has accepted Merck's (MRK) new supplemental Biologics License Application (sBLA) for KEYTRUDA for the first-line treatment of patients with recurrent o.

The last quarter of 2018 for Merck & Co/MSD was once again all about its cancer immunotherapy Keytruda, which powered the company to a healthy rise in ...

EMD Serono, which is the name Merck KGaA operates under in the U.S. and Canada, is expanding its R&D facility in Billerica, Mass., one of four such life ...

Drugmaker Merck ended the fourth quarter of 2018 with net income of $1.8 billion, compared to a net loss of $1 billion in the same period a year prior.

NEW YORK/WASHINGTON (Reuters) - U.S. drugmaker Merck & Co Inc said on Tuesday that its Chief Executive Ken Frazier plans to testify at a Senate hearing ...

Merck & Co. (MRK) highlighted its oncology, vaccines, hospital and specialty care, and animal health businesses as its key growth drivers in 2018.

Investors of all stripes like Johnson & Johnson (NYSE:JNJ) because its careful assembly of related healthcare businesses has allowed the conglomerate to ...

Merck and Pfizer have been laggards so far in 2019. Technical warnings occurred on Dec. 4 when both set multiyear highs and both received downgrades.

The FDA has accepted a new drug application and supplemental new drug application for two Merck antibacterial agents, the company announced. According ...

The FDA has accepted two new antibacterial drug applications from Merck & Co, both of which have received Priority Review. The first application is for the ...

Merck is known for its signature drug, Keytruda, an immunotherapy drug currently registered to treat seven different types of cancer that brings in nearly $2 billion ...

Merck (NYSE:MRK) recently reported its Q4 2018 earnings, which were slightly below our estimates. The company's top line and bottom line grew in ...

Merck & Co Inc. (NYSE:MRK) Q4 2018 Earnings Conference Call February 01, 2019 08:00 AM ET Company Participants Teri Loxam - IR Ken Frazier - Chairman ...

Speeches on shark antibody cancer fighters, self-assembling circuits and superbug-fighting vaccines sound like a TED talk agenda. How about a pharma TED ...

RUPERT ? Tucked into the rolling Taconic Mountains in the northwestern corner of Bennington County lies 3,162 acres of preserved land open to the public ...

After strong earnings from aircraft manufacturing behemoth Boeing Co. (BA - Get Report) propelled the U.S. market higher Wednesday, stocks were mixed ...

The FDA has started a speedy review of Merck KGaA and Pfizer's new combination regimen for advanced kidney cancer, setting up a possible approval in June ...

Merck's (MRK) relatively newer products like Keytruda, Gardasil and Bridion are likely to drive fourth-quarter sales. However, genericization of key drugs and ...

Jim Cramer explains why Merck could be the perfect stock for an uncertain market.

Merck (NYSE:MRK)'s (MRK) Q4 earnings call contextualized the company's pipeline progress in 2018, financial management, investments for the future, and ...

Merck KGaA will invest $70 million to expand its R&D hub in Billerica, Massachusetts, the company said Wednesday. The investment is part of the pharma's ...

Looking at top Wall Street opinions, CorMedix, Inc. (NYSE: CRMD) has recently made its way into the research list of ROTH Capital ? signaling that their ...

Merck & Co awaits full Keynote-426 data with Keytruda plus Inlyta, while Seattle Genetics looks beyond Adcetris with enfortumab vedotin. yellow pin in calendar ...

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Merck (MRK) have what it takes? Let's find ...

Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift card! While some investors are already well ...

We worked with climate researcher Four Twenty Seven to look at all S&P 500 companies' physical sites and assess them for exposure to the effects of climate ...

3D Exhibits and client Merck Animal Health took top honors in the 2019 VETTY Awards, winning Best of Show in the Tradeshow Experience category.

"Squawk Box" reports on Merck's earnings report. Merck revenues beat $10.998 vs 10.990 estimated. EPS beats $1.04 vs $1.03 estimated.

KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that the Board of ...

Yesterday, Merck, a German multinational pharmaceutical, chemical and life sciences company, and Tencent, a Chinese multinational investment holding ...

Merck (NYSE:MRK) is set to report its Q4 2018 earnings on February 1, and we expect the company to post mid-single-digit top line growth and low double-digits ...

The shares of Merck & Co., Inc. (NYSE:MRK) dropped by -1.56% or -$1.25 from its last recorded high of $80.19 which it attained on December 04 to close at ...

Fourth-Quarter 2018 Worldwide Sales Were $11.0 Billion, an Increase of 5 Percent, Including a 3 Percent Negative Impact from Foreign Exchange; Full-Year ...

Merck has been battling allegations of anticompetitive vaccine "bundling,? and this week, the company fell short in an effort to stay a lawsuit and force plaintiffs ...

BILLERICA, Massachusetts, Feb. 6, 2019 /PRNewswire/ -- Merck KGaA, Darmstadt, Germany investing $70 million in U.S. Research & Development Hub ...

Codexis (CDXS) is up 13% premarket on light volume in reaction to its multiyear agreement with Merck (MRK) under which CDXS will install its CodeEvolver pr.

Merck KGaA (OTCPK:MKGAY) out-licenses exclusive rights to two DNA-dependent protein kinase (DNA-PK) inhibitors, M981 (formerly VX-984) and a preclinical ...

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Feb. 4) ...

Shares of Pfizer and Merck fell on Wednesday after Wall Street downgraded the drugmakers on increased competition and the loss of patent protection.

Merck has entered into an exclusive licensing agreement with US-based Vertex handing back rights to two DNA-dependent protein kinase (DNA-PK) inhibitors ...

The FDA designates Merck's (MRK) 15-valent pneumococcal conjugate vaccine V114 a Breakthrough Therapy for the prevention of invasive pneumococcal ...

Merck (NYSE: MRK) announces its next round of earnings this Friday, Feb. 1. Here is Benzinga's everything-that-matters guide for this Friday's Q4 earnings ...

Teva PharmaceuticalsThe scope of the Report:Get a detailed segmentation of the global Anti-Cancer Drug market according to the type of product and ...

Earnings for each Share (EPS) are the part of a company's profit allocated to respectively outstanding share of common stock. EPS serves as a pointer to a ...

Following are excerpts from a CNBC interview with Merck Chairman and CEO, Stefan Oschman, and CNBC's Steve Sedgwick and Geoff Cutmore. SS: Okay, so ...

The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, ...

Check out the companies making headlines before the bell: Viacom ? The media company earned an adjusted $1.12 per share for its latest quarter, 9 cents a ...

Our market researchers follow industry-best primary and secondary research methodologies to compile highly comprehensive and meticulous reports.

KENILWORTH, N.J.--(BUSINESS WIRE)--Jan 22, 2019--Merck (NYSE: MRK), known as MSD outside the United States and Canada, will hold its fourth-quarter ...

The Ebola outbreak in Congo has claimed hundreds of lives, and Merck is planning another vaccine shipment to help officials fighting the spread of the virus.

A federal judge on Thursday denied a request by some 80 out-of-state plaintiffs who sued Merck & Co Inc over its shingles vaccine Zostavax to have their cases ...

Five 2019 sessions of the Stockmanship & Stewardship program were announced at the Cattle Industry Convention and NCBA Trade Show last week.

Barrow Hanley Mewhinney & Strauss Llc decreased Honeywell International Inc (HON) stake by 5.95% reported in 2018Q3 SEC filing. Barrow Hanley ...

The size of the Pigment market is viewed in terms of the Share of Market, Total Available Market as well as Served Available Market. Not only does the study ...

Merck KGaA has signed on to a collaboration with Chinese internet giant Tencent, focused on developing digital, artificial intelligence-based platforms to help ...

The shares of Merck & Co., Inc. (NYSE:MRK) has been pegged with a rating of Buy by Citigroup in its latest research note that was published on October 16th, ...

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Jan. 31) ...

Two companies have come together to develop a vaccine for Rhodococcus equi (R. equi) pneumonia in foals and other infections.

The ?Mycoplasma Testing Market? report gives an informative picture of the Mycoplasma Testing market by the system, consolidation, and investigation of study ...

Merck & Co., Inc. (NYSE:MRK) notched a 0.64% intraday gain moving at $79.02. When the opening bell rang, the price was $78.56. The number of shares that ...

It's a busy day for drug makers, although analysts can't seem to agree on what stocks look best. Where we were: Drug makers topped the Dow Jones Industrial ...

Pharmaceutical firm Merck KGaA has been granted a US patent that combines artificial intelligence (AI) and blockchain technology in an attempt to "protect ...

Merck KGaA (MRK.XE) said Wednesday that it has signed a strategic collaboration agreement with Tencent Holdings Ltd. (0700.HK) to develop digital ...

The Edge Consulting Group CEO Jim Osman tells Proactive Investors the investment research company that focuses on company spin-offs has compiled a ...

Merck KGaA (OTCMKTS:MKGAF) has been making waves when its stock price touched $107.85 following the most recent close. The stock is traded on OTC in ...

The recently announced collaboration will enable AAHA to do more to foster individual well-being and a healthy workplace culture.

Investors often closely follow fundamental and technical data. Even with all the evidence, it can be tough to determine if the economy and the markets are.

Merck & Co. (MRK) making a luring appeal, share price swings at $78.94 with percentage change of -0.10% during Thursday trading session. Along recent loss ...

Check out the companies making headlines before the bell: Merck ? Merck earned an adjusted $1.04 per share for the fourth quarter, beating estimates by a ...

Over the next two weeks, the U.S. Food and Drug Administration (FDA) has three upcoming decisions. Here's a look.

The Global ?Microbiology & Bacterial Culture for Industrial Testing market 2019 ? report is a meticulous study of the global Microbiology & Bacterial Culture for ...

Global Upper Respiratory Tract Infection Treatment Market 2019 Summary. The report on global Upper Respiratory Tract Infection Treatment Market studies the ...

The global ?1,6-Hexanediamine? Market research report enlists the vital and practical information with regards to market situation. The present scenario of 1 ...

Did you know that over 60% of drugs in today's pipelines are developed by emerging biotechs? A great responsibility bearing numerous challenges, such as ...

Stefan Oschmann, chief executive officer at Merck KGaA, discusses the growth of the company's portfolio, the impact of the German economy on the business, ...

Earnings Expectations: If we take an observation in front to the next coming days, Street analysts have hope earnings growth of 29.20% for this year and may be ...

Key Statistics: Merck & Company, Inc. (NYSE:MRK) shares fell and closed the day at $78.94, with the percent change of -0.1%. The company has its outstanding.

The clinical development program for avelumab, known as JAVELIN, involves at least 30 clinical programs and more than 9000 patients evaluated across more ...

The FDA has approved a new biosimilar of Roche's breast cancer drug Herceptin, from Samsung Bioepis and Merck & Co, ahead of the original drug's US ...

Modular and podular laboratory and manufacturing allow rapid reconfiguration to support development of drugs for diverse patient populations.

Checking in on some valuation rankings, Merck & Co., Inc. (MRK) has a Value Composite score of 52. Developed by James O'Shaughnessy, the VC score uses.

Merck, the oldest pharmaceutical company operating in the world today and also one of the most important companies in its sector, has recently received a ...

Market study report Titled Global ?Single Use Bioreactors Market? 2019 Industry Research Report recently published on e-marketresearch.com is the key ...

Merck & Co., Inc. (NYSE:MRK) enjoyed a fine run from the open in trading on 02/12/2019 with increased volume coming into the shares and a close higher.

Merck's (MRK) investigational pneumococcal vaccine V114 gets FDA's Breakthrough Therapy designation for prevention of invasive pneumococcal disease.